Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease.

Theile D, Haefeli WE, Seitz HK, Millonig G, Weiss J, Mueller S.

Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E17-22. doi: 10.1111/j.1530-0277.2012.01901.x. Epub 2012 Jul 24.

PMID:
22827451
2.

Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.

Tsertsvadze T, Dolmazashvili E, Abutidze A, Sharvadze L, Karchava M.

Georgian Med News. 2008 Dec;(165):38-42.

PMID:
19124915
3.

Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers.

Trabut JB, Thépot V, Nalpas B, Lavielle B, Cosconea S, Corouge M, Vallet-Pichard A, Fontaine H, Mallet V, Sogni P, Pol S.

Alcohol Clin Exp Res. 2012 Aug;36(8):1407-11. doi: 10.1111/j.1530-0277.2012.01737.x. Epub 2012 Mar 8.

PMID:
22404692
4.

Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients.

Nakai K, Tanaka H, Hanada K, Ogata H, Suzuki F, Kumada H, Miyajima A, Ishida S, Sunouchi M, Habano W, Kamikawa Y, Kubota K, Kita J, Ozawa S, Ohno Y.

Drug Metab Dispos. 2008 Sep;36(9):1786-93. doi: 10.1124/dmd.107.020073. Epub 2008 May 30.

5.

Reduction of liver stiffness by antiviral therapy in chronic hepatitis B.

Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Kitahara S, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Shimazaki H, Arima Y, Suzuki K, Yoshioka K.

J Gastroenterol. 2011 Nov;46(11):1324-34. doi: 10.1007/s00535-011-0444-4. Epub 2011 Aug 6.

PMID:
21822591
6.

Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis.

Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK.

World J Gastroenterol. 2010 Feb 28;16(8):966-72.

7.
8.

Albumin and procollagen type I gene regulation in alcohol and viral-induced human liver disease.

Annoni G, Arosio B, Santambrogio D, Gagliano N, Zern MA.

Boll Ist Sieroter Milan. 1991-1992;70(1-2):391-7.

PMID:
1670041
9.

Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.

Fung J, Lai CL, Chan SC, But D, Seto WK, Cheng C, Wong DK, Lo CM, Fan ST, Yuen MF.

Am J Gastroenterol. 2010 May;105(5):1116-22. doi: 10.1038/ajg.2009.665. Epub 2009 Nov 17.

PMID:
19920809
10.

Prospective Evaluation of Liver Stiffness Using Transient Elastography in Alcoholic Patients Following Abstinence.

Gianni E, Forte P, Galli V, Razzolini G, Bardazzi G, Annese V.

Alcohol Alcohol. 2017 Jan;52(1):42-47. doi: 10.1093/alcalc/agw053. Epub 2016 Aug 19.

PMID:
27542989
11.

Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters.

Ogasawara K, Terada T, Katsura T, Hatano E, Ikai I, Yamaoka Y, Inui K.

Drug Metab Pharmacokinet. 2010;25(2):190-9.

12.

Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development.

Hanada K, Nakai K, Tanaka H, Suzuki F, Kumada H, Ohno Y, Ozawa S, Ogata H.

Drug Metab Pharmacokinet. 2012;27(3):301-6. Epub 2011 Dec 13.

13.

Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.

Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R.

Eur J Gastroenterol Hepatol. 2010 Apr;22(4):474-80. doi: 10.1097/MEG.0b013e328332dd0a.

PMID:
19887952
14.

Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, Ebner T, Terasaki T.

Drug Metab Dispos. 2012 Jan;40(1):83-92. doi: 10.1124/dmd.111.042259. Epub 2011 Oct 12.

15.

Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs.

Andersen ES, Weiland O, Leutscher P, Krarup H, Westin J, Moessner B, Konopski Z, Frigstad SO, Kjær M, Christensen PB, Weis N.

Scand J Gastroenterol. 2011 Jun;46(6):760-6. doi: 10.3109/00365521.2011.565068. Epub 2011 Mar 28.

PMID:
21438780
16.

Glutathione-S-transferase GST M1 "null" genotype and the risk of alcoholic liver disease.

Savolainen VT, Pjarinen J, Perola M, Penttilä A, Karhunen PJ.

Alcohol Clin Exp Res. 1996 Nov;20(8):1340-5.

PMID:
8947308
17.

Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.

Gómez-Dominguez E, Mendoza J, García-Buey L, Trapero M, Gisbert JP, Jones EA, Moreno-Otero R.

Aliment Pharmacol Ther. 2008 Mar 1;27(5):441-7. Epub 2007 Dec 10.

18.

The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.

Tamano M, Kojima K, Akima T, Murohisa T, Hashimoto T, Uetake C, Sugaya T, Nakano M, Hiraishi H, Yoneda M.

Hepatogastroenterology. 2012 May;59(115):826-30. doi: 10.5754/hge11255.

PMID:
22469726
19.

Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.

Harada N, Soejima Y, Taketomi A, Yoshizumi T, Ikegami T, Yamashita Y, Itoh S, Kuroda Y, Maehara Y.

Transplantation. 2008 Jan 15;85(1):69-74. doi: 10.1097/01.tp.0000297248.18483.16.

PMID:
18192914
20.

Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.

Kim BK, Oh HJ, Park JY, Kim DY, Ahn SH, Han KH, Park Y, Yoo EJ, Park YN, Kim SU.

Liver Int. 2013 Feb;33(2):180-9. doi: 10.1111/liv.12020.

PMID:
23295050

Supplemental Content

Support Center